SCHEMBL1933293

SCHEMBL1933293

Brc1ccc([Mg]I)cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3027928 0.71
SCHEMBL18508 0.71
SCHEMBL2869266 0.69
SCHEMBL6004069 0.69
SCHEMBL6912177 0.69
SCHEMBL9635137 0.68 CYP2A6 (0.73)
SCHEMBL1868904 0.67
Methane SCHEMBL21489530 0.67 CYP2A6 (0.89)
SCHEMBL21518322 0.67
SCHEMBL3138002 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2507234-B1 IMIDAZOLE DERIVATIVES AS ALDOSTERONE SYNTHASE INHIBITORS NOVARTIS AG (CH) 2014-03-12 EP disclosed
US-8575160-B2 Imidazole derivatives as aldosterone synthase inhibitors NOVARTIS AG (CH) 2013-11-05 US disclosed
US-20130065893-A1 IMIDAZOLE DERIVATIVES AS ALDOSTERONE SYNTHASE INHIBITORS NOVARTIS AG (CH) 2013-03-14 US disclosed
EP-2507234-A1 IMIDAZOLE DERIVATIVES AS ALDOSTERONE SYNTHASE INHIBITORS Novartis AG (CH) 2012-10-10 EP disclosed
WO-2011064376-A1 IMIDAZOLE DERIVATIVES AS ALDOSTERONE SYNTHASE INHIBITORS NOVARTIS AG (CH) 2011-06-03 WO disclosed